Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BBIO
Stock Latest News
The Fly
BridgeBio Pharma price target lowered to $102 from $104 at BofA
17h ago
BBIO
Premium
The Fly
BridgeBio Pharma price target raised to $120 from $115 at Piper Sandler
18h ago
BBIO
Premium
The Fly
BridgeBio Pharma price target lowered to $91 from $94 at Citi
19h ago
BBIO
Premium
The Fly
BridgeBio Pharma assumed with a Buy at UBS
5d ago
BBIO
Premium
Company Announcements
BridgeBio Wins FDA Priority Review for Infigratinib
7d ago
8K
BBIO
Premium
The Fly
BridgeBio announces real-world evidence, Phase 3 ATTRibute CM sub-analyses
8d ago
BBIO
Premium
The Fly
BridgeBio Pharma presents results from Phase 3 CALIBRATE trial of encaleret
8d ago
BBIO
Premium
The Fly
BridgeBio Pharma price target lowered to $156 from $157 at Barclays
13d ago
BBIO
Premium
TipRanks Newswire
Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
14d ago
BBIO
KRYS
Premium
Ratings
Analyst Reiterates Buy on BridgeBio as Multiple Late-Stage Catalysts and Infigratinib Priority Review Drive Diversified Growth Outlook
14d ago
BBIO
Premium
The Fly
BridgeBio Pharma announces FDA acceptance of oral infigratinib NDA
14d ago
BBIO
Premium
Ratings
BridgeBio Pharma: Buy Rating Reiterated on Strong FORTIFY Phase 3 Data; 12-Month $120 Price Target Maintained
14d ago
BBIO
Premium
The Fly
BridgeBio Pharma presents new data from interim analysis of FORTIFY study
15d ago
BBIO
Premium
The Fly
Mizuho biotech analysts hold an analyst/industry conference call
18d ago
BBIO
BIIB
Premium
The Fly
BridgeBio Pharma announces results from trial of tafamidis in ATTR-CM
27d ago
BBIO
Premium
The Fly
BridgeBio Pharma presents new exploratory analyses from PROPEL 3 at ESPE
1M ago
BBIO
Premium
Ratings
BridgeBio Pharma: Buy Rating Reiterated as Acoramidis Data Strengthen Efficacy Profile and 12-Month Price Target Held at $120
2M ago
BBIO
Premium
The Fly
BridgeBio Pharma files $500M mixed securities shelf
2M ago
BBIO
BBOT
Premium
The Fly
BridgeBio Pharma price target raised to $110 from $96 at Mizuho
2M ago
BBIO
Premium
Company Announcements
BridgeBio Pharma Expands Access to Rare Disease Therapies
2M ago
8K
BBIO
Premium
The Fly
BridgeBio Pharma presents new analyses from Phase 3 ATTRibute-CM study
2M ago
BBIO
Premium
The Fly
BridgeBio Pharma doses first patient in ASCEND-ATTR trial
2M ago
BBIO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
